Divisadero Street Capital Management, LP
-13.75%
3M Return
$18.670
+0.461 (+2.47%)At close
Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
Omada Health Inc is a good buy right now due to its current price of $21.55, which is below the average analyst price target range of $25 to $35. The company's recent performance shows a 5-day change of +5.79% and a year-to-date change of +44.63%, indicating strong momentum. Additionally, the gross margin has improved significantly to 72.62% in Q2 2026, reflecting operational efficiency. However, the main risk is the high forward P/E ratio of 136.99, suggesting that the stock may be overvalued if growth does not meet expectations.

Omada Health to Release Q3 2026 Results on November 5

Challenges and Opportunities in Chronic Disease Management

Omada Health Executive Stock Sale Details

Omada Health Launches Independent Cost Savings Model for GLP-1 Program

CEO Duffy's Share Disposition at Omada Health: Key Insights
Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure. It operates in the Healthcare sector.
Omada Health Inc is a good buy right now due to its current price of $21.55, which is below the average analyst price target range of $25 to $35. The company's recent performance shows a 5-day change of +5.79% and a year-to-date change of +44.63%, indicating strong momentum. Additionally, the gross margin has improved significantly to 72.62% in Q2 2026, reflecting operational efficiency. However, the main risk is the high forward P/E ratio of 136.99, suggesting that the stock may be overvalued if growth does not meet expectations.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.